← Evidence map

ArticleHematology. American Society of Hematology. Education Program2022

Transplant for TP53-mutated MDS and AML: because we can or because we should?

Jurjen Versluis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

17 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36485102